01 2Allergan Inc.
02 1Bausch Health, Canada Inc.
01 22191773
02 12817524
01 1HALOBETASOL PROPIONATE | TAZAROTENE
02 2Tazarotene
01 2Gel
02 1LOTION
01 22015-08-10
02 12031-11-09
Patent Expiration Date : 2015-08-10
Date Granted : 2004-08-10
Brand Name : TAZORAC
Patent Number : 2191773
Filing Date : 1995-06-07
Strength per Unit : 0.05%
Dosage Form : Gel
Human Or VET : Human
Route of Administration : Topical
Patent Expiration Date : 2015-08-10
Date Granted : 2004-08-10
Patent Expiration Date : 2015-08-10
Date Granted : 2004-08-10
Brand Name : TAZORAC
Patent Number : 2191773
Filing Date : 1995-06-07
Strength per Unit : 0.10%
Dosage Form : Gel
Human Or VET : Human
Route of Administration : Topical
Patent Expiration Date : 2015-08-10
Date Granted : 2004-08-10
Patent Expiration Date : 2031-11-09
Date Granted : 2019-11-05
HALOBETASOL PROPIONATE, TAZAROTENE
Brand Name : DUOBRII
Patent Number : 2817524
Filing Date : 2011-11-09
Strength per Unit : 0.01% w / w ; 0.045% w / w
Dosage Form : LOTION
Human Or VET : Human
Route of Administration : TOPICAL
Patent Expiration Date : 2031-11-09
Date Granted : 2019-11-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
